Bone Morphogenetic Protein (BMP) Market
Bone Morphogenetic Protein (BMP) Market Size, Share & Trends Analysis Report by Product Type (Recombinant Human BMP-2, Recombinant Human BMP-7, Other BMP Variants), by Application (Spinal Fusion Surgeries, Dental Implants, Trauma & Fracture Healing), and Forecast Period (2026–2035)
Industry Overview
Bone Morphogenetic Protein (BMP) market is poised for steady growth, with valuations expected to rise from $452.6 million in 2025 to $772.2 million by 2035, reflecting a CAGR of 5.6%. BMPs are essential biologics widely used in bone regeneration, particularly in spinal fusion and dental surgical procedures, due to their proven efficacy in promoting bone healing. The market’s expansion is being driven by the rising prevalence of bone disorders, an increasingly aging population, and growing awareness of advanced orthopedic therapies. Moreover, escalating healthcare expenditures, particularly in developed regions, along with ongoing advancements in regenerative medicine, are further accelerating the adoption of BMP-based therapies. Hospitals and specialized surgical centers remain key end-users, as they provide access to complex procedures and advanced biologics, ensuring higher procedural volumes and better patient outcomes.
Recent industry developments underscore the emphasis on innovation and delivery system enhancements. In March 2025, Medtronic announced the availability of its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS) for chronic pain management. This cutting-edge device automatically senses biological signals along the spinal cord and adjusts stimulation in near real-time, delivering personalized therapy aligned with patients’ daily movements. Such innovations illustrate the competitive focus on enhancing biologics delivery, improving patient adherence, and expanding treatment efficacy. These strategic advancements, alongside collaborations and product portfolio expansions by leading BMP manufacturers, are driving both market penetration and clinical adoption, reinforcing the BMP market’s strong growth trajectory over the next decade.
Market Dynamics
The Gold Standard of Healing: The Dominance of rhBMP-2
Recombinant human BMP-2 (rhBMP-2) commands the biologics market by consistently driving robust, predictable bone growth in complex spinal fusions. By effectively mimicking the body’s natural osteogenic processes, it eliminates the need for painful bone harvesting and significantly improves surgical success rates. In January 2024, CGBIO’s next-generation rhBMP-2 bone graft, NOVOSIS PUTTY, secured U.S. FDA Breakthrough Device Designation. This designation fast-tracks its clinical review and potential U.S. market entry, promising an innovative solution that merges sustained-release delivery with a ceramic scaffold to optimize targeted bone regeneration in advanced orthopedic and spinal procedures.
Spinal Fusion Soars: Aging Populations Fuel Global Demand Surge
Driven by the global increase in spinal disorders and the growing aging population, spinal fusion procedures are witnessing significant growth. Innovations in biologics and BMP-enhanced implants are enhancing surgical outcomes, boosting adoption rates, and reshaping spine care worldwide. In May 2025, PubMed Central review highlights that the integration of biologics with additive manufacturing technologies is revolutionizing spinal surgery by promoting tissue regeneration, improving fusion success, and enabling patient-specific implant solutions. The study underscores that these combined technological advancements are redefining treatment approaches in regenerative orthopedics and spinal repair.
Market Segmentation
- Based on product type, the market is segmented into recombinant human BMP-2, recombinant human BMP-7, and other BMP variants.
- Based on application, the market is segmented into spinal fusion, dental implants, trauma & fracture, and tissue engineering & regenerative medicine.
Dental implants are the fastest-growing application in the market
Dental implants are currently the fastest-growing area within the Bone Morphogenetic Protein (BMP) market, driven primarily by the increasing demand for cosmetic and restorative dentistry. With rising awareness of oral health and aesthetics, more patients are opting for dental implants to replace missing teeth and restore functional and visual appeal. BMPs play a critical role in enhancing bone regeneration at implant sites, improving osseointegration and long-term implant stability. The aging population, coupled with higher incidences of tooth loss and periodontal diseases, is further fueling the adoption of BMP-assisted dental procedures. Additionally, technological advancements in implant design and minimally invasive surgical techniques are making these treatments more accessible and effective, supporting continued market growth in this segment.
Regional Outlook
The global bone morphogenetic protein (BMP) market is further divided by region, including North America (the US and Canada), Europe (the UK, Germany, France, Italy, Spain, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia and New Zealand, ASEAN Countries, and the Rest of Asia-Pacific), and the Rest of the World (the Middle East & Africa, and Latin America).
North America is the leading region in the market
North America dominates the Bone Morphogenetic Protein (BMP) market owing to its advanced healthcare infrastructure, well-established hospitals, and high volumes of spinal, dental, and orthopedic surgeries. Strong adoption of innovative biologics, favorable reimbursement policies, and robust R&D investment further reinforce the region’s market leadership and sustained growth trajectory. In March 2025, Zimmer Biomet highlighted its diverse portfolio of orthopedic and musculoskeletal innovations at the AAOS 2025 Annual Meeting, unveiling advanced hip, knee, and reconstructive technologies designed to improve surgical outcomes and procedural efficiency. These advancements underscore growing opportunities in the orthopedic care ecosystem, which bolsters the demand for adjunct biologics such as bone morphogenetic proteins in regenerative and fusion procedures.
Market Players Outlook
The major companies operating in the global bone morphogenetic protein (BMP) market include Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet, and Globus Medical, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative Protection development to maintain their market positioning.
Recent Development
- In February 2026, Medtronic announced that the S. Food and Drug Administration (FDA) granted Premarket Approval for its INFUSE Bone Graft in Transforaminal Lumbar Interbody Fusion (TLIF) at one and two levels, making it the only PMA?approved growth factor bone graft for this procedure. The approval follows Breakthrough Device Designation and clinical evidence showing >90?% fusion rates, marking a significant advancement for BMP?based biologics in complex spine surgery.
- In December 2025, Zimmer Biomet partnered with OneStep to integrate advanced mobility data analytics into its mymobility care management platform, enabling clinicians and patients to track recovery more effectively after orthopedic procedures. This collaboration reflects growing emphasis on data?driven postoperative care, enhancing functional outcomes and supporting demand for complementary biologics and implant solutions in musculoskeletal treatment pathways.
The Report Covers
- Market value data analysis of 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global bone morphogenetic protein (BMP) market
- Based on the availability of data, information related to new protections and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Bone Morphogenetic Protein Market Sales Analysis – Product Type| Application ($ Million)
- Bone Morphogenetic Protein Market Sales Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Bone Morphogenetic Protein Market Trends
- Market Recommendations
- Market Determinants
- Market Drivers
- Drivers For Bone Morphogenetic Protein Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For Bone Morphogenetic Protein Market: Impact Analysis
- Market Opportunities
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Bone Morphogenetic Protein Market Revenue and Share by Manufacturers
- Bone Morphogenetic Protein Type Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Johnson & Johnson
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Medtronic
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Stryker
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Zimmer Biomet
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Globus Medical
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Johnson & Johnson
- Key Company Analysis
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership And Collaboration
- Bone Morphogenetic Protein Market Sales Analysis By Product Type ($ Million)
- Recombinant Human BMP-2
- Recombinant Human BMP-7
- Other BMP Variants
- Bone Morphogenetic Protein Market Sales Analysis By Application ($ Million)
- Spinal Fusion
- Trauma & Fracture
- Dental
- Tissue Engineering & Regenerative Medicine
- Regional Analysis
- North American Bone Morphogenetic Protein Market Sales Analysis – Product Type| Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- European Bone Morphogenetic Protein Market Sales Analysis – Product Type| Application | Country ($ Million)
- Macroeconomic Factors for Europe
- UK
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia-Pacific Bone Morphogenetic Protein Market Sales Analysis – Product Type| Application | Country ($ Million)
- Macroeconomic Factors for Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia & New Zealand
- ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- Rest of Asia-Pacific
- Rest of the World Bone Morphogenetic Protein Market Sales Analysis – Product Type | Application| Country ($ Million)
- Macroeconomic Factors for the Rest of the World
- Latin America
- Middle East and Africa
- Company Profiles
- Anika Therapeutics, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Baxter International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BioHorizons IPH, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bioventus Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Bone Therapeutics
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cell & Growth Factor Biotechnology Company, Ltd
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cellumed Co., Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Collagen Matrix, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Dentsply Sirona Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Geistlich Pharma AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Globus Medical, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Integra LifeSciences Holdings Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Johnson & Johnson
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Kuros Biosciences AG
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Maxigen Biotech Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- NuVasive, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Olympus Terumo Biomaterials Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Orthofix Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- RTI Surgical Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- SeaSpine Holdings
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Straumann Group
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Stryker Corporation
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Wright Medical Group N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Xtant Medical Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Zimmer Biomet Holdings, Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Anika Therapeutics, Inc.
1. Global Bone Morphogenetic Protein Market Research and Analysis Product Type, 2025-2035 ($ Million)
2. Global Recombinant Human BMP-2 Market Research and Analysis By Region, 2025-2035 ($ Million)
3. Global Recombinant Human BMP-7 Market Research and Analysis By Region, 2025-2035 ($ Million)
4. Global Other BMP Variants Market Research and Analysis By Region, 2025-2035 ($ Million)
5. Global Bone Morphogenetic Protein Market Research and Analysis By Application, 2025-2035 ($ Million)
6. Global Bone Morphogenetic Protein For Spinal Fusion Market Research and Analysis By Region, 2025-2035 ($ Million)
7. Global Bone Morphogenetic Protein For Trauma & Fracture Market Research and Analysis By Region, 2025-2035 ($ Million)
8. Global Bone Morphogenetic Protein For Dental Market Research and Analysis By Region, 2025-2035 ($ Million)
9. Global Bone Morphogenetic Protein For Tissue Engineering & Regenerative Medicine Market Research and Analysis By Region, 2025-2035 ($ Million)
10. Global Bone Morphogenetic Protein Market Research and Analysis By Region, 2025-2035 ($ Million)
11. North American Bone Morphogenetic Protein Market Research and Analysis By Country, 2025-2035 ($ Million)
12. North American Bone Morphogenetic Protein Market Research and Analysis By Product Type, 2025-2035 ($ Million)
13. North American Bone Morphogenetic Protein Market Research and Analysis By Application, 2025-2035 ($ Million)
14. European Bone Morphogenetic Protein Market Research and Analysis By Country, 2025-2035 ($ Million)
15. European Bone Morphogenetic Protein Market Research and Analysis By Product Type, 2025-2035 ($ Million)
16. European Bone Morphogenetic Protein Market Research and Analysis By Application, 2025-2035 ($ Million)
17. Asia-Pacific Bone Morphogenetic Protein Market Research and Analysis By Country, 2025-2035 ($ Million)
18. Asia-Pacific Bone Morphogenetic Protein Market Research and Analysis By Product Type, 2025-2035 ($ Million)
19. Asia-Pacific Bone Morphogenetic Protein Market Research and Analysis By Application, 2025-2035 ($ Million)
20. Rest of the World Bone Morphogenetic Protein Market Research and Analysis By Country, 2025-2035 ($ Million)
21. Rest of the World Bone Morphogenetic Protein Market Research and Analysis By Product Type, 2025-2035 ($ Million)
22. Rest of the World Bone Morphogenetic Protein Market Research and Analysis By Application, 2025-2035 ($ Million)
1. Global Bone Morphogenetic Protein Market Research and Analysis Product Type, 2025 Vs 2035 ($ Million)
2. Global Recombinant Human BMP-2 Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
3. Global Recombinant Human BMP-7 Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
4. Global Other BMP Variants Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
5. Global Bone Morphogenetic Protein Market Research and Analysis By Application, 2025 Vs 2035 ($ Million)
6. Global Bone Morphogenetic Protein For Spinal Fusion Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
7. Global Bone Morphogenetic Protein For Trauma & Fracture Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
8. Global Bone Morphogenetic Protein For Dental Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
9. Global Bone Morphogenetic Protein For Tissue Engineering & Regenerative Medicine Market Research and Analysis By Region, 2025 Vs 2035 ($ Million)
10. US Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
11. Canada Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
12. UK Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
13. France Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
14. Germany Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
15. Italy Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
16. Spain Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
17. Russia Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
18. Rest of Europe Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
19. India Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
20. China Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
21. Japan Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
22. South Korea Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
23. Australia and New Zealand Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
24. ASEAN Economies Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
25. Rest of Asia-Pacific Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
26. Latin America Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
27. Middle East and Africa Bone Morphogenetic Protein Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
